Cargando…
Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic
SIMPLE SUMMARY: Despite all the efforts and advances made in the treatment of breast cancer, this pathology continues to be one of the main causes of cancer death in women, particularly triple-negative breast cancer (TNBC), and, although to a lesser degree, HER-2 receptor-positive tumors. Chemothera...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909490/ https://www.ncbi.nlm.nih.gov/pubmed/35267507 http://dx.doi.org/10.3390/cancers14051198 |